CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Adhera Therapeutics Inc Company Snapshot
Adhera Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adhera Therapeutics Inc with three other companies in this sector in UNITED STATES : Marker Therapeutics Inc(Pre-Reincorporation) (2019 sales of $213,194.00 ), Cellular Biomedicine Group Inc ($339,920.00 ), and Oasmia Pharmaceutical AB ($218,512.80 of which 65% was Sales of goods).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Adhera Therapeutics Inc
  Stock Performance Chart for Adhera Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): .09
(Figures in U.S. Dollars)
1 Week 13.2%   13 Weeks 42.3%  
4 Weeks 127.3%   52 Weeks -45.3%  
 
Adhera Therapeutics Inc Key Data:
  Ticker: ATRX Country: United States
  Exchanges: NAS BLN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 252,000
(Year Ending Jan 2020).
Employees: 1
  Currency: U.S. Dollars Market Cap: 951,084
  Fiscal Yr Ends: December Shares Outstanding: 10,869,530
  Share Type: Common Closely Held Shares: 4,128,551
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.